WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Feb 16-24, 2020. https://www.who.int/ publications-detail/report-of-the-who-chinajoint-mission-on-coronavirus-disease-2019-(covid-19) (accessed March 22, 2020).

This document does not address the indications of genetic testing in patients affected by inherited arrhythmias and their family members. Diagnostic, prognostic, and therapeutic implications of the results of genetic testing are also not included in this document because this topic has been covered by a recent publication 1 coauthored by some of the contributors of this consensus document, and it remains the reference text on this topic. Guidance for the evaluation of patients with idiopathic ventricular fibrillation, sudden arrhythmic death syndrome, and sudden unexplained death in infancy, which includes genetic Contents lists available at ScienceDirect

Our analysis suggests that transcatheter device closure of VSD is safe and yields good results. The limitations of this study are difficulties in analyzing different devices individually, and segregating the different VSD types. Further stratification by type of VSD, age of patients, and prevention of complications is needed before this can be recommended for routine treatment.